The Menopausal Disorder Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the menopausal disorder treatment has significantly increased in the recent years. It is projected to rise from $10.69 billion in 2024 to $11.50 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. This growth has been hi
The Menopausal Disorder Treatment Global Market is projected to grow to $15.30 billion by 2029, with a compound annual growth rate (CAGR) of 7.4%.
Download Your Free Sample of the 2025 Menopausal Disorder Treatment Market Report and Uncover Key Trends Now!The key drivers in the menopausal disorder treatment market are:
• Rising expenditure on healthcare infrastructure
• Greater focus on women's health initiatives
• Increased collaborations between pharmaceutical companies and research institutions
• Impact of urbanization and lifestyle changes on menopausal health
The menopausal disorder treatment market covered in this report is segmented –
1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications
2) By Stages: Menopause, Postmenopause, Perimenopause
3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
The key trends in the menopausal disorder treatment market are:
• There is a growing shift towards natural and herbal remedies for menopausal disorder treatment.
• The integration of artificial intelligence in treatment planning is an emerging trend.
• Wearable devices for real-time symptom monitoring are becoming increasingly prevalent.
• A greater focus is being placed on holistic wellness programs that address menopause.
Major players in the menopausal disorder treatment market are:
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Merck & Co Inc.
• Novartis AG
• Bayer AG
• Bristol-Myers Squibb Company
• Sanofi SA
• AstraZeneca plc
• Eli Lilly and Company
• Novo Nordisk A/S
• Abbott Laboratories
• GlaxoSmithKline plc
• Teva Pharmaceutical Industries Ltd.
• Ipsen SA
• Dr. Reddy’s Laboratories Ltd.
• Theramex
• Besins Healthcare
• Mithra Pharmaceuticals
• Duchesnay USA
• Fervent Pharmaceuticals
• Joylux Inc.
• TherapeuticsMD Inc.
North America was the largest region in the menopausal disorder treatment market in 2024